{"title":"Rare cancers, the continued agenda for progress – editor’s special foreword","authors":"D. O’Connor","doi":"10.1080/21678707.2020.1821529","DOIUrl":null,"url":null,"abstract":"Rare cancers affect one in five new patients with cancer and this second special edition highlights some of the continued activity in the field (first special edition[1]). Of note since the first s...","PeriodicalId":12118,"journal":{"name":"Expert Opinion on Orphan Drugs","volume":"8 1","pages":"309 - 310"},"PeriodicalIF":0.8000,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/21678707.2020.1821529","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Opinion on Orphan Drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/21678707.2020.1821529","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Rare cancers affect one in five new patients with cancer and this second special edition highlights some of the continued activity in the field (first special edition[1]). Of note since the first s...
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
